Dr Reddys Laboratories (RDY) Change in Accured Expenses (2014 - 2016)

Dr Reddys Laboratories (RDY) recorded quarterly Change in Accured Expenses of $13.7 million in Q4 2016, up 77.35% quarter-over-quarter from $7.7 million in Q3 2016, and down 59.14% on a YoY basis from $33.5 million in Q1 2016.

Dr Reddys Laboratories (RDY) Change in Accured Expenses (2014 - 2016) Analysis & Trends

Dr Reddys Laboratories' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at $13.7 million for Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -144.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -234.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -12.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -14.30 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.89 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 10.02 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 23.00 Mn
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2016 13.70 Mn
Dec 31, 2016 13.70 Mn
Sep 30, 2016 7.72 Mn
Sep 30, 2016 7.72 Mn
Jun 30, 2016 -61.39 Mn
Jun 30, 2016 -61.39 Mn
Dec 31, 2015 33.53 Mn
Dec 31, 2015 33.53 Mn
Sep 30, 2015 1.66 Mn
Sep 30, 2015 1.66 Mn
Jun 30, 2015 -26.08 Mn
Jun 30, 2015 -26.08 Mn
Dec 31, 2014 15.29 Mn
Dec 31, 2014 15.29 Mn
Sep 30, 2014 -20.03 Mn
Sep 30, 2014 -20.03 Mn
Jun 30, 2014 -401,729.25
Jun 30, 2014 -401,729.25